Production (Stage)
Remedent, Inc.
REMI
$0.01
$0.000.00%
OTC PK
| 03/31/2021 | 12/31/2020 | 09/30/2020 | 06/30/2020 | 03/31/2020 | |
|---|---|---|---|---|---|
| Revenue | 324.50K | 304.60K | 229.20K | 149.40K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 324.50K | 304.60K | 229.20K | 149.40K | -- |
| Cost of Revenue | 163.60K | 161.90K | 128.10K | 82.90K | -- |
| Gross Profit | 160.90K | 142.60K | 101.10K | 66.40K | -- |
| SG&A Expenses | 501.40K | 264.90K | 352.70K | 465.60K | -- |
| Depreciation & Amortization | 34.50K | 37.80K | 45.80K | 56.00K | -- |
| Other Operating Expenses | -378.90K | -459.50K | -459.50K | -459.50K | -- |
| Total Operating Expenses | 320.60K | 5.00K | 67.00K | 145.00K | -- |
| Operating Income | 4.00K | 299.60K | 162.20K | 4.40K | -- |
| Income Before Tax | 8.20K | 522.10K | 259.70K | 88.30K | -- |
| Income Tax Expenses | 300.00 | 1.40K | 700.00 | 700.00 | -- |
| Earnings from Continuing Operations | 0.01 | 0.52 | 0.26 | 0.09 | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 300.00 | -7.30K | 11.40K | 19.30K | -- |
| Net Income | 8.10K | 513.40K | 270.40K | 106.80K | -- |
| EBIT | 4.00K | 299.60K | 162.20K | 4.40K | -- |
| EBITDA | 41.20K | 340.90K | 211.50K | 63.90K | -- |
| EPS Basic | 0.01 | -0.01 | -0.03 | -0.03 | -- |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -- |
| EPS Diluted | 0.01 | -0.02 | -0.03 | -0.04 | -- |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -- |
| Average Basic Shares Outstanding | 59.99M | 59.99M | 59.99M | 59.99M | -- |
| Average Diluted Shares Outstanding | 79.98M | 79.98M | 79.98M | 79.98M | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |